• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Clin Invest . FNDC4 and FNDC5 Attenuate SARS-CoV-2 S1-Induced Inflammatory Responses in Human Adipose Tissue

tetano

Editor, Senior Moderator
Eur J Clin Invest


. 2026 May;56(5):e70215.
doi: 10.1111/eci.70215.
FNDC4 and FNDC5 Attenuate SARS-CoV-2 S1-Induced Inflammatory Responses in Human Adipose Tissue

Gabriela Neira[SUP] 1 2 3 [/SUP], Julia Hernández-Castañeda[SUP] 1 [/SUP], Victoria Catalán[SUP] 1 2 3 4 [/SUP], Sara Becerril[SUP] 1 2 3 4 [/SUP], Marina Martín[SUP] 5 [/SUP], Víctor Valentí[SUP] 2 3 4 6 [/SUP], Rafael Moncada[SUP] 2 3 4 7 [/SUP], Camilo Silva[SUP] 2 3 4 8 [/SUP], Javier Gómez-Ambrosi[SUP] 1 2 3 4 [/SUP], Javier Escalada[SUP] 2 3 4 8 [/SUP], Gema Frühbeck[SUP] 1 2 3 4 8 [/SUP], Amaia Rodríguez[SUP] 1 2 3 4 [/SUP]


Affiliations
Abstract

Background: Adipose tissue is recognised as a SARS-CoV-2 reservoir and potential infection site. We herein characterised SARS-CoV-2 entry points in visceral (VAT) and subcutaneous (SAT) adipose tissue from people with obesity and determined whether the adipo-myokines FNDC4 and FNDC5 modulate SARS-CoV-2 spike glycoprotein subunit 1 (S1)-induced inflammation in adipocytes and macrophages.
Methods: Plasma concentrations of FNDC4, FNDC5 and angiotensin-converting enzyme 2 (ACE2) were measured in 183 participants with obesity and normal weight. Expression of SARS-CoV-2 host cell entry receptors was analysed in paired VAT and SAT biopsies (n = 121). The effects of FNDC4 and FNDC5 on S1-induced inflammatory responses were evaluated in vitro using human visceral adipocytes and THP-1-derived macrophages.
Results: Obesity was associated with higher circulating ACE2 and increased expression of SARS-CoV-2 entry receptors (ACE2, CD147, DPP4 and neuropilin-1) in VAT, whereas plasma FNDC4 and FNDC5 levels were reduced. FNDC4, FNDC5 and ACE2 co-localised with macrophage populations in VAT, and FNDC4 and FNDC5 transcripts positively correlated with genes involved in viral entry and priming. Both adipo-myokines attenuated S1-induced M1 macrophage polarisation and HMGB1 secretion and reduced HMGB1 expression in adipocytes.
Conclusion: Reduced FNDC4 and FNDC5 levels in obesity may amplify SARS-CoV-2 S1-induced inflammatory responses in VAT macrophages and adipocytes.

Keywords: ACE2; SARS‐CoV‐2; adipose tissue inflammation; myokines; obesity.

 
Back
Top